CVS Health said on May 9, 2024 it issued and sold 5.400% Senior Notes due 2029 with a principal amount of $1,000,000,000 and 5.550% Senior Notes due 2031 with a principal amount of $1,000,000,000.

1. 01

   CVS Health said on May 9, 2024 it issued and sold 5.400% Senior Notes due 2029 with a principal amount of $1,000,000,000 and 5.550% Senior Notes due 2031 with a principal amount of $1,000,000,000.

2. 02

   The company said it also issued and sold on the same day 5.700% Senior Notes due 2034 with a principal amount of $1,250,000,000 and 6.000% Senior Notes due 2044 with a principal amount of $750,000,000.

3. 03

   CVS Health said it sold 6.050% Senior Notes due 2054 with a principal amount of $1,000,000,000 together with the other notes, and that the notes were offered under a Form S-3ASR registration statement (File No. 333-272200) dated May 25, 2023.

4. 04

   The company said the notes are issued under a Senior Indenture dated August 15, 2006 with The Bank of New York Mellon Trust Company, N.A., as trustee. It also said it may issue additional senior debt securities under that indenture.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.